Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.

Pharmacokinetics and Bioavailability of Quercetin Glycosides in Humans

Abstract

Due to its potentially beneficial impact on human health, the polyphenol quercetin has come into the focus of medicinal interest. However, data on the bioavailability of quercetin after oral intake are scarce and contradictory. Previous investigations indicate that the disposition of quercetin may depend on the sugar moiety of the glycoside or the plant matrix. To determine the influence of the sugar moiety or matrix on the absorption of quercetin, two isolated quercetin glycosides and two plant extracts were administered to 12 healthy volunteers in a four‐way crossover study. Each subject received an onion supplement or quercetin‐4′‐O‐glucoside (both equivalent to 100 mg quercetin), as well as quercetin‐3‐O‐rutinoside and buckwheat tea (both equivalent to 200 mg quercetin). Samples were analyzed by HPLC with a 12‐channel coulometric array detector. In human plasma, only quercetin glucuronides, but no free quercetin, could be detected. There was no significant difference in the bioavailabilityand pharmacokinetic parameters between the onion supplement and quercetin‐4′‐O‐glucoside. Peak plasma concentrations were 2.3 ± 1.5 μg•mL −1 and 2.1 ± 1.6 μg•mL −1 (mean ± SDJ and were reached after 0.7 ± 0.2 hours and 0.7 ± 0.3 hours, respectively. After administration of buckwheat tea and rutin, however, peak plasma levels were—despite the higher dose—only 0.6 ± 0.7 μg•mL −1 and 0.3 ± 0.3 μg•mL −1 , respectively. Peak concentrations were reached 4.3 ± 1.8 hours after administration of buckwheat tea and 7.0 ± 2.9 hours after ingestion of rutin. The terminal elimination half‐life was about 11 hours for all treatments. Thus, the disposition of quercetin in humans primarily depends on the sugar moiety. To a minor extent, the plant matrix influences both the rate and extent of absorption in the case of buckwheat tea administration compared with the isolated compound. The site of absorption seems to be different for quercetin‐4′‐O‐glucoside and quercetin‐3‐O‐rutinoside. The significance of specific carriers on the absorption of quercetin glycosides, as well as specific intestinal b‐glucosidases, needs to be further evaluated.

Overview

Integrity signals

Registry

Crossref · 10.1177/00912700122010366

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 33 references

Research works printed but not linked: 10

  1. Graefe EU, 1999, Relative systemic availability of the flavonoids quercetin and rutin in humans, Arch Pharm Pharm Med Chem, 332, 20
  2. Wittig J, Identification of quercetin glucuronides in human plasma by HPLC‐MS/MS, J Chromatogr B
  3. Plumb GW, 2000, Uptake and metabolism of quercetin glycosides in Caco‐2 cell cultures and everted rat gut sacs, Polyphenols Communications, 2, 401
  4. Matthes I, 1992, Mucusmodelle zur Untersuchung von intestinalen Absorptionsmechanismen: vergleich des Mucusmodells mit Absorptionsmodellen in vivo und in situ zur Vorhersage intestinaler Wirkstoffabsorption, Pharmazie, 47, 787
  5. HagelsH:Analytische pharmazeutische phytochemische sowie inter‐ und intraindividuelle Untersuchungen zuFagopyrum‐Arten; Studie zur Pharmakokinetik des Rutins.PhD dissertation Freie Universität Berlin 1996.
  6. NolteK:Entwicklung eines reproduzierbaren in‐vitro Resorptionsmodells mit Schweinedarm.PhD dissertation Ruprecht‐Karls‐Universität 1998.
  7. Day AJ, 2000, Quercetin glucuronidation and effect of conjugation position on biological activity, Polyphenols Communications, 2, 403
  8. Shimoi K, 2000, Deglucuronidation of flavonoids at inflammation site and its effect on vascular endothelial cells, Polyphenols Communications, 1, 297
  9. Wittig J, 2000, Beta‐glucuronidase activity of human endothelial tissues in an in‐vitro model using primary monolayer cultures of human umbilical vein endothelial cells (HUVEC), Polyphenols Communications, 2, 459
  10. O'Leary KA, 2000, The role of β‐glucuronidases in flavonoid metabolism in humans, Polyphenols Communications, 2, 405

Cited by

See all 649

Metadata

Authors
Graefe, E. U., Wittig, J., Mueller, S., Riethling, A., Uehleke, B., Drewelow, B., Pforte, H., Jacobasch, G., Derendorf, H., & Veit, M.
Affiliations
  • University of Rostock (DE)
  • German Institute of Human Nutrition (DE)
  • University of Florida Health (US)
Corresponding author
Veit, Markus
Venue
The Journal of Clinical Pharmacology
Publisher
Wiley
Published
2001-05
Volume
41
Issue
5
Pages
492-499
ISSN
  • 0021-9754 (ISSN-L)
  • 0091-2700
  • 1552-4604
OpenAlex
W2144843569
Cited by
649
References
33
Citations by year
2026: 38 · 2025: 25 · 2024: 17 · 2023: 30 · 2022: 27 · 2021: 33 · 2020: 35 · 2019: 32 · 2018: 38 · 2017: 34 · 2016: 34 · 2015: 29 · 2014: 23 · 2013: 27 · 2012: 28
FWCI
13.04
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
  • Health Sciences › Medicine › Pharmacology (medical) › Flavonoids in Medical Research
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Seed and Plant Biochemistry
Keywords
quercetin, quercetin glycosides, rutin, bioavailability, pharmacokinetics, sugar moiety, glucuronidation, intestinal absorption, polyphenols, human plasma, elimination half-life
MeSH terms
Adult, Biological Availability, Female, Glucosides, Half-Life, Humans, Male, Metabolic Clearance Rate, Plant Extracts, Quercetin, Rutin, Cross-Over Studies, Area Under Curve, Fagopyrum, Onions, Flavonols

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacokinetics and Bioavailability of Quercetin Glycosides in Humans. https://app.cochat.ai/papers/10.1177/00912700122010366
The paper
Graefe, E. U., Wittig, J., Mueller, S., Riethling, A., Uehleke, B., Drewelow, B., Pforte, H., Jacobasch, G., Derendorf, H., & Veit, M. (2001). Pharmacokinetics and Bioavailability of Quercetin Glycosides in Humans. The Journal of Clinical Pharmacology. https://doi.org/10.1177/00912700122010366

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.